This federal contract award to 10X Genomics, Inc., a life sciences technology company, was issued by the Centers for Disease Control and Prevention (CDC) Pittsburgh. The $109,800 firm fixed price purchase order is for the company's specialized genomic analysis platforms, reagents, instruments, and bioinformatics software. These products, which include Chromium Next GEM Single Cell Kits, Visium Spatial Gene Expression systems, and Xenium Analyzers, support advanced biomedical research across various scientific domains such as infectious diseases, cancer, neurological disorders, and age-related conditions. While most of 10X Genomics' federal contracts are not set aside, the company has been awarded several small business set-aside contracts, particularly with the National Institute of Allergy and Infectious Diseases. The contract is part of a larger indefinite delivery contract (IDC) with the National Institute on Aging, valued at up to $7,000,000 and running through July 2029, focused on providing optimization slides, reagent kits, and reagent delivery methods to support research into neurological diseases and disorders.
Generated 6/13/25, 9:51 AM